Last Updated: November 8, 2026

GUANETHIDINE MONOSULFATE Drug Patent Profile

Name: GUANETHIDINE MONOSULFATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Guanethidine Monosulfate, and what generic alternatives are available?

Guanethidine Monosulfate is a drug marketed by Watson Labs and is included in two NDAs.

The generic ingredient in GUANETHIDINE MONOSULFATE is guanethidine monosulfate. There is one drug master file entry for this compound. Additional details are available on the guanethidine monosulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for GUANETHIDINE MONOSULFATE?
What are the global sales for GUANETHIDINE MONOSULFATE?
What is Average Wholesale Price for GUANETHIDINE MONOSULFATE?

Summary for GUANETHIDINE MONOSULFATE

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	459
DailyMed Link:	GUANETHIDINE MONOSULFATE at DailyMed

Drug patent expirations by year for GUANETHIDINE MONOSULFATE

Medical Subject Heading (MeSH) Categories for GUANETHIDINE MONOSULFATE

Adrenergic Agents
Antihypertensive Agents
Sympatholytics

Anatomical Therapeutic Chemical (ATC) Classes for GUANETHIDINE MONOSULFATE

C02CC	Guanidine derivatives
C02C	ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02	ANTIHYPERTENSIVES
C	Cardiovascular system

S01EX	Other antiglaucoma preparations
S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for GUANETHIDINE MONOSULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	GUANETHIDINE MONOSULFATE	guanethidine monosulfate	TABLET;ORAL	086113-001	Mar 26, 1985		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	GUANETHIDINE MONOSULFATE	guanethidine monosulfate	TABLET;ORAL	086114-001	Mar 26, 1985		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.